Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)

In this paper by Maguire and colleagues (BMJ 2021;374:n1674, doi:10.1136/bmj.n1674, published 27 July 2021), co-author Christine Miaskowski’s surname was misspelt. This has been corrected.


Read Original Article: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) »